Last reviewed · How we verify
Blank control
A blank control is not a drug but rather a negative control used in pharmaceutical research and clinical trials to establish baseline measurements.
At a glance
| Generic name | Blank control |
|---|---|
| Also known as | Baseline |
| Sponsor | Nanjing Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Blank controls contain no active pharmaceutical ingredient and serve as a reference point to measure the efficacy and safety of actual therapeutic agents. They are essential in experimental design to distinguish true drug effects from placebo effects, natural disease progression, or measurement artifacts.
Approved indications
Common side effects
Key clinical trials
- Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation (NA)
- hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease (PHASE1, PHASE2)
- A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain (PHASE1)
- DBM-1152A Inhalation Solution in Chinese Healthy Subjects (PHASE1)
- DBM-1152A Inhalation Solution in Healthy Volunteers (PHASE1)
- Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients (NA)
- Visual Influences on Vestibular Adaptation (NA)
- The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |